pc_tata_chem_202890446
TRANSCRIPT
-
7/29/2019 PC_Tata_Chem_202890446
1/9
TataChemicalsOverseassubsidiarydisappoints;cashflowstoremainstressed
FERTILISER:QuarterlyUpdate 11February2013
PhillipCapital (India) Pvt. Ltd.
Results disappoint: Tata Chemicals topline has been inline with estimates;
howeverEbitda
disappointed
significantly
(almost
by
about
18%).
Key
reasons
for
divergenceare1/largestquarterly lossofRs620mn inBMGLsubsidiary(this is
despite consolidation of British salt) and 2/lower than estimated profits in
domestic fertilizers. Unfavorable prices/cost pressures in Africa and lower
demand intheUKhalvedmarginsqoqto7%.AsaresultoverallEbitdadegrew
19%qoqtoRs5.1bn.Thelongtermforexrevaluationfurtherstressedtheweak
EbitdabyaboutRs810mn.ThefallinEbitdawaslargelymadeupbyhigherother
income(inclRs1.3bnonaccountofforexgains;adjforcomparison)and lower
tax;whichcurtailedfurtherfallinreportedPATtoRs2.24bn(degrew13%qoq).
However,theadj.PATofRs1.33bn,degrew40%qoq;muchbelowourest.
BMGLanddomestic fertilizer;marginwoesenlarged inQ3:Domestic fertilizer
division
continues
to
be
under
stress;
with
overall
Ebitda/mt
at
Rs
2247/mtagainstaverageof8qtravgof Rs2,700/mt;a fallofabout 20%.We expect in
P&K, Tata Chem to have earned wafer thin margins of about US$ 20~25/mt.
Furtherexpensivefeedandunfavourablerealizations,pressuredAfricasodaash
operations and that of UK has been under stress due to stiff competition. We
dontseethewoesforthetwinassetsreversinganytimesoon.
Q3review&outlookofkeybusinessesacrossgeography
Tata Chem (domestic): Weak INR and easing feed costs helped post 8% gr in
chemical EBIT qoq. Fertiliser margins were pressured by weak P&K margins.
HelpedbyweakINR,weexpectchem.marginstoremainhealthyinthenearterm
BMGL: Cost pressures, stiff competition, weather related uncertainty could
continuetoexertpressureonoperations/results
GCIP:With
utilization
rates
already
at
97%;
the
growth
seems
to
be
tapering
off.
Likely lower realizations in FY14% (down by 2~3%) and likely increase in
feedcosts (shale gas prices expected to rise) we expect margins to remain
subdued.WealsohighlightmarginsforGCIPhavecomeofffrom30%inQ2FY12
toabout24%atpresent.WeexpectEbitdatolikelyshrinkthanrise
IMACID:Onalowerbase,weexpectresultstoimprovebutbelikelysubdued
Rallis:Competition,costpressuresonaweakdemandbackgroundhavehardhit
thenumbers,weexpectmarginstoimprovesomewhatinFY14E
Others:LossesincreasedfromRs37mntoRs170mnqoq
Cutestimates, downgrade to Neutral:Wecutourestimatessignificantlygoing
by 1/muted growth in GCIP 2/persisting margin pressures (for P&K) and
lengthened
working
capital
cycle
led
by
delayed
subsidy
reimbursements
and
3/no firm timelines on addressing operational issues in BMGL. While volumes
couldpullbackinH1FY14E;thesustenanceofmarginsremainsuncertain.Wesee
heightened need for cash, given scheduled debt repayments, capex funding
(Babrala,TripuraandGabonUreaprojects)andlengthenedworkingcapitalcycle
followingdelayedsubsidyreimbursementsfromthegovernment. Thisdoesraise
prospectsofmonetizinginvestments(mktvalueoflistedinvtisRs40/sh;valueof
unlisted investmentcouldalmostequal itscurrentdebtofRs70bn) inbridging
the resourcedeficit.However,consideringtheneartermheadwindsthatcloud
earningsoutlook,wedowngradeourratingtoNeutralandlowerPTtoRs385(Rs
400earlier).
Downgradeto
Neutral
TTCHIN|CMPRS355TARGETRS385(+9%)
CompanyData
O/SSHARES(MN): 255
MARKETCAP(RSBN): 90
MARKETCAP(USDBN): 1.7
52 WKHI/LO(RS): 382/299
LIQUIDITY3M(USDMN): 4.3
FACEVALUE(RS): 10
ShareHoldingPattern,%
PROMOTERS: 31.1
FII/NRI: 15.9
FI/MF
:
28.5NONPROMOTERCORP.HOLDINGS: 3.0
PUBLIC&OTHERS: 21.6
PricePerformance,%
1mth 3mth 1yr
ABS 5.7 11.2 2.4
RELTOBSE 4.3 7.8 7.6
PriceVs.Sensex(Rebasedvalues)
80
100
120
140
Apr10 J a n11 Oct11 J ul12
TataChem BSESensex
Source:PhillipCapitalIndiaResearch
OtherKeyRatios
Rsmn FY12 FY13E FY14E
NetSales 136,551 153,111 153,396
EBITDA 21,527 18,856 21,956
NetProfit 8,37 6 3,931 7,773
EPS,Rs 32.9 34.3 35.1
PER,X
10.8 11.5 10.1EV/EBIDTA,x 6.4 8.2 6.7
EV/NetSales,x 1.0 1.0 1.0
ROE,% 13.2 12.2 11.5
Source:PhillipCapitalIndiaResearchEst.
GauriAnand(+912266679943)[email protected]
SaurabhRathi(+912266679951)[email protected]
-
7/29/2019 PC_Tata_Chem_202890446
2/9
2
of
9
11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE
Quarterlyresults
Rsmn Q2FY13 Q3FY12 Q3FY13 yoy% QoQ% 9MFY12 9MFY13 yoy%
NetSales 41,655 37,939 41,705 9.9 0.1 102,574 113,569 10.7
(Inc)/Decinstock (2,221) (222) 2,918 1417.2 231.4 5,732 1,266 122.1
As%ofSales 5 1 7 6 1
RawMaterialConsumed 11,027 12,365 13,356 8.0 21.1 31,721 30,627 3.4
As%
of
Sales
26
33 32
31
27
Costoftradedgoods 8,656 5,243 2,943 43.9 66.0 17,055 14,109 17.3
As%ofSales 21 14 7 17 12
EmployeeExpenses 2,811 2,535 2,796 10.3 0.5 7,085 8,415 18.8
As%ofSales 7 7 7 7 7
Power&Fuel 4,063 3,793 4,529 19.4 11.5 10,697 12,208 14.1
As%ofSales 10 10 11 10 11
Freight&forwarding charges 4,308 3,553 4,157 17.0 3.5 9,984 12,196 22.2
As%ofSales 10 9 10 10 11
OtherExpenses 6,709 3,989 5,908 48.1 11.9 11,167 18,852 68.8
As%ofSales 16 11 14 11 17
TotalExpenditure 35,353 32,541 36,606 12.5 3.5 85,781 97,672 13.9
EBITDA 6,303 5,398 5,099 5.5 19.1 16,793 15,897 5.3
EBIDTA% 15 14 12
Depreciation 1402 1228 1378 12.2 1.7 3,727 4,147 11.3
EBIT
4,901
4,170 3,72110.8
24.1 13,066
11,749
10.1
EBIT% 12 11 9 13 10
Interestexpenses 1144 1111 1184 6.6 3.5 3,062 3,572 16.7
Exceptional items 124 468 813 73.6 558.2 1,017 1,553 52.6
OtherIncome 760 613 1730 182.2 127.5 2,224 3,326 49.5
PBT 4,393 3,204 3,454 7.8 21.4 11,211 9,950 11.2
TotalTax 1158 645 733 13.6 36.8 2,636 2,341 11.2
Taxrate% 26 20 21 24 24
PAT 3,235 2,559 2,722 6.3 15.9 8,574 7,609 11.3
ShareofProfitsinAssoc 1 22 8 62.4 1540.0 22 20
Minorityint 667 300 473 57.8 29.1 1,560 1,705 9.3
RPAT 2,568 2,238 2,241 0.1 12.7 6,992 5,884 15.8
APAT 2,253 2,441 1,331 45.5 40.9 7,080 5,660 20.1
OPM% 15.1 14.2 12.2 16.4 14.0
NPM% 5.4 6.4 3.2 6.9 5.0
AEPS 8.8 9.6 5.2 45.5 40.9 27.8 22.2 20.0
Source:Company,PhillipCapitalIndiaResearch
-
7/29/2019 PC_Tata_Chem_202890446
3/9
3
of
9
11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE
TataChems30.6%stakeinEPMMiningisvaluedatRs8bnorRs32/shEPMMining(EPM)EPMisaUS$200mnmarketcapcompanyfocusedondevelopinga
premiumspecialtypotashfertilizer(namedSulfateofPotash) inUtah,USA.Itclaimsto
control102,000acresofbrinedepositwitharesourcepotentialof100mmtatdepthof
only 300 feet. According to EPM, its likely to be on of the lowest cost producer as it
wouldprocessnaturalSOPbysolarevaporationmethod.GiventhenaturalSOP(priced
atUS$
675/mt)
is
at
about
40%
premium
to
MOP
(priced
at
US$
475/mt),
the
profits
are
likelytobemuchhigher.
EPMhascommenceddrillingandawaits43101filingforresourceconfirmationwhichit
hasfiledthismonth.EPMexpectstaxbreaksfortheprojectongroundsthatitwouldbe
abletogenerateemployment,notwithstanding thetaxbenefitsitestimatesNPVofUS$
527 mn (10% discount rate) with commercial production in 2016. Tata Chem has
invested about Rs 800 mn (US$ 16 mn) for 30.6% stake in EPM Mining. We work the
valueofTataChemsinvestmentinEPMMiningatUS$158mnorRs8bn.
AboutSOPSulfateofPotash (SOP) isapremiumproductforchloridesensitivecrops.
Thisisahighvaluefertilizerthathasworldwidedemandofmorethan6mmtandisused
mainly on high value specialty crops like Citrus fruits, Strawberries, Peaches, some
vegetables,tobacco
and
cotton.
EPMminingdetails
NameoftheProduct SulfateofPotash
ResourceEstimate inmmt 100
EPMMIniingMarketCap US$mn 200
Estimatedrealisation/costs
MOP $/mt 475
SOP $/mt 675
Costofproduction $/mt 130
EstRevin2016 US$mn 621
EstEbitdain2016 US$mn 276
ProjectedNAV(@10%discount) US$mn 527
TataChem'sholding
inEPMMining mnsh 37
in
EPM
Mining
%
stake
30.60%
Investedamount US$mn 16
ValueinEPM(30.6%stake) US$mn 158
Source:EPMMiningVenturesInc.Presentation
DerivationofPriceTargetDeepValue
FigsinRs.Mn. FY14E Comments
Fert&Chembusiness 142,712 Valuedat6.5xfY14Eebitda
InvestmentsQuoted 9,680 quotedinvtassumedat30%discounttocmp
Investmentsunquoted 2,586
Valueoffirm 154,978
Add:CashFY14E 5,028
Less:DebtFY14E 61,339
Enterprise value 98,667 30%stakeinepmmining
TargetPrice
Rs.
385
CMPRs. 355
Upsidefromcurrentlevels % 9
Source:Company,PhillipCapitalIndiaResearch
-
7/29/2019 PC_Tata_Chem_202890446
4/9
4
of
9
11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE
Segmentalbreakup
Rsmn Q2FY13 Q3FY12 Q3FY13 yoy% QoQ% 9MFY12 9MFY13 yoy%
Revenues
InorganicChemicals 19,102 16,670 19,252 15.5 0.8 48,237 57,005 18.2
Fertilisers 17,229 17,287 18,431 6.6 7.0 41,916 42,638 1.7
OtherAgriInputs(Rallis) 5,378 4,168 4,266 2.3 20.7 12,757 14,087 10.4
Others
257
176
214
21.816.6 527
706 34.0
Total 41,966 38,300 42,162 10.1 0.5 103,437 114,435 10.6
Less:Intersegmentrevenue 311 361 458 26.8 47.2 862 867 0.5
Netsales/incomefromoperations 41,655 37,939 41,705 9.9 0.1 102,574 113,569 10.7
EBIT
InorganicChemicals 3,278 2,609 2,706 3.7 17.5 9,229 9,496 2.9
Fertilisers 1,663 1,672 1,153 31.0 30.7 4,110 3,096 24.7
OtherAgriInputs(Rallis) 998 230 422 82.9 57.8 1,629 1,831 12.4
Others (37) (254) (170) 33.2 356.5 556 340 38.7
Total 5,902 4,257 4,110 3.4 30.4 14,413 14,083 2.3
As%ofSales
InorganicChemicals 45.9 43.9 46.2 47.0 50.2
Fertilisers 41.4 45.6 44.2 40.9 37.5
OtherAgri
Inputs
(Rallis)
12.9
11.0 10.2 12.4
12.4
Others
PBIT%
InorganicChemicals 17.2 15.6 14.1 19.1 16.7
Fertilisers 9.7 9.7 6.3 9.8 7.3
OtherAgriInputs(Rallis) 18.6 5.5 9.9 12.8 13.0
Others 14.5 144.7 79.3 105.5 48.2
As%ofPBIT
InorganicChemicals 55.5 61.3 65.8 64.0 67.4
Fertilisers 28.2 39.3 28.1 28.5 22.0
OtherAgriInputs(Rallis) 16.9 5.4 10.3 11.3 13.0
Others 0.6 6.0 4.1 3.9 2.4
Source:Company,
PhillipCapital
India
Research
-
7/29/2019 PC_Tata_Chem_202890446
5/9
5
of
9
11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE
TCL'sOverseasoperationalperformancereview
Q1FY13 Q2FY13 Q3FY13 Comments
GCIP
NetSales(Rsmn) 6,690 6,450 6,900 Capacityexpansions supportstoplinegr.
EBIT(Rsmn) 1,780 1,510 1,630 I mprovesonalowerbase
EBIT% 27 23 24
SalesVolumes
(000
Mt)
575 566 629
RealisationRs/Mt 11,635 11,396 10,970 Changeinproductmix;lowersrealisation
Re/USD 54.2 55.2 54.2
RealisationUS$/Mt 215 206 203
EBIT/Mt(INR) 3,096 2,668 2,591
EBIT/Mt(US$) 57 48 48
BMGL
NetSales(Rsmn) 5,810 5,790 5,560 Revenuedegrewledbylowerrealisations
EBIT(Rsmn) 740 750 370 CostpressurespullsmarginsdowninKenya
EBIT% 13 13 7
SalesVolumes(000Mt) 299 289 288 Kenyaproductiondegrewalmost20%;howeverhigherinventoryhelpsreportsflatsalesvol.qoq
RealisationRs/Mt 19431 20035 19306
Re/USD 54.2 55.2 54.2
RealisationUS$/Mt 358 363 357 Changeinproductmix;lowersrealisation
EBIT/Mt
(INR)
2475 2595 1285
EBIT/Mt(US$) 46 47 24
IMACID(Rsmn)
NetSales 420 1,740 2,030 Volumesimproveonalowerbase,howeverlowerrealisationshurttoplinegrowth
EBIT 100 100 80
EBIT% 24 6 4
APAT 120 70 60
Source:Company,PhillipCapitalIndiaResearch
Operatingmarginsperformance(%) Salesvol.('000mt)
-40.0
-30.0
-20.0
-10.0
0.0
10.0
20.0
30.0
Q1FY09
Q2FY09
Q3FY09
Q4FY09
Q1FY10
Q2FY10
Q3FY10
Q4FY10
Q1FY11
Q2FY11
Q3FY11
Q4FY11
Q1FY12
Q2FY12
Q3FY12
Q4FY12
Q1FY13
Q2FY13
Q3FY13
TCL consl. EBIT margins Fert. Div. margins
Chem. Div. margins
0
500
1,000
1,500
2,000
2,500
Q1FY09
Q2FY09
Q3FY09
Q4FY09
Q1FY10
Q2FY10
Q3FY10
Q4FY10
Q1FY11
Q2FY11
Q3FY11
Q4FY11
Q1FY12
Q2FY12
Q3FY12
Q4FY12
Q1FY13
Q2FY13
Q3FY13
Soda Ash Urea DAP/NPK Salt
Source:Company,PhillipCapitalIndiaResearch
-
7/29/2019 PC_Tata_Chem_202890446
6/9
6
of
9
11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE
Financials
IncomeStatement
Y/EMar,Rsmn FY12 FY13E FY14E FY15E
Netsales
136,551
153,111
153,396 157,295
Growth,% 23 12 0 3
Totalincome 136,551 153,111 153,396 157,295
Operatingexpenses 115,024 134,254 131,440 134,883
EBITDA(Core) 21,527 18,856 21,956 22,412
Growth,% 15.5 (12.4) 16.4 2.1
Margin,% 15.8 12.3 14.3 14.2
Depreciation 5,087 5,521 5,457 5,557
EBIT 16,440 13,335 16,499 16,855
Growth,% 15.5 (12.4) 16.4 2.1
Margin,% 15.8 12.3 14.3 14.2
Interestpaid 4,270 5,740 5,674 4,715
OtherNonOperatingIncome 3,188 3,939 1,170 1,170
Non
recurring
Items
1,524
1,553
0 0Pretaxprofit 13,834 10,010 11,994 13,309
Taxprovided 3,439 3,619 3,423 3,765
NetProfit 8,376 7,869 7,773 8,747
Growth,% 23.3 4.6 2.1 10.9
NetProfit(adjusted) 8,376 8,759 8,943 9,917
Unadj.shares(m) 255 255 255 255
Wtdavgshares(m) 255 255 255 255
BalanceSheet
Y/EMar,Rsmn FY12 FY13E F Y14E FY15E
Cash&bank 16,780 4,881 5,02 8 2,830
Debtors 23,107 27,266 27,317 28,011
Inventory 18,634 20,230 19,806 20,325
Loans&advances 8,555 8,555 8,55 5 8,555
Totalcurrentassets 67,076 60,932 60,706 59,722
Investments 6,097 6,097 6,09 7 6,097
Grossfixedassets 100,211 105,703 113,593 118,777
Less:Depreciation 56,267 61,788 67,245 72,802
Add:CapitalWIP 5,492 7,890 5,18 4 5,921
Netfixedassets 49,436 51,805 51,532 51,896
Noncurrentassets 65,594 63,587 63,587 63,587
Totalassets 189,546 183,765 183,266 182,645
Currentliabilities 42,943 29,002 28,722 29,301
Provisions 15,439 12,962 13,190 13,422
Totalcurrentliabilities 58,382 41,964 41,913 42,723
Noncurrent
liabilities
64,131
69,351
62,357 53,407
Totalliabilities 122,513 111,314 104,270 96,130
Paidupcapital 2,548 2,548 2,54 8 2,548
Reserves&surplus 61,632 66,596 72,344 79,064
Shareholdersequity 68,661 74,572 81,231 87,951
Totalequity&liabilities 189,546 183,765 183,266 182,645
Source:Company,PhillipCapitalIndiaResearchEstimates
CashFlow
Y/EMar,Rsmn FY12 FY13E FY14E F Y15E
Pretax
profit
13,834
9,982 11,994 13,309
Depreciation 5,087 5,52 1 5,4 57 5,5 57
Chginworkingcapital 4,719 20,168 322 403
Totaltaxpaid 3,808 3,619 3,423 3,765
Otheroperatingactivities 4,700 4,70 0 4,7 00 4,7 00
Cashflowfromoperatingactivities 15,094 3,585 19,051 19,400
Capitalexpenditure 9,619 7,890 5,184 5,921
Chgininvestments 1,618 0 0 0
Cashflowfrominvestingactivities 11,236 7,890 5,184 5,921
Freecashflow 3,858 11,475 13,867 0
Debtraised/(repaid) 6,116 5,220 6,994 8,950
Dividend(incl.tax) 2,905 2,90 5 3,1 95 3,1 95
Otherfinancingactivities 9,930 9,930 9,930 9,930
Cash
flow
from
financing
activities
2,512
3,290
13,615
16,483Netchgincash 1,346 14,765 251 3,004
ValuationRatios&PerShareData
FY12 FY13E F Y14E FY15E
EPS,Rs 32.9 34.3 35.2 34.3
BVPS,Rs 269.4 292.6 318.8 345.2
DPS,Rs 10.0 10.0 11.0 11.0
Returnonassets(%) 7.6 5.4 6.6 6.9
Returnonequity(%) 13.2 12.2 11.5 10.3
ReturnonInvestedcapital(%) 29.1 17.7 19.9 20.3
RoIC/Costofcapital(x) 3.2 1.9 2.2 2.3
RoIC Costofcapital(%) 19.9 8.6 10.9 11.5
Returnoncapitalemployed(%) 9.4 6.6 7.8 8.1
Costofcapital(%) 9.2 9.1 9.0 8.9
RoCE Costofcapital(%) 0.3 (2.6) (1.2) (0.8)
Assetturnover(x) 2.5 2.3 1.9 2.0
Sales/Totalassets(x) 0.8 0.8 0.8 0.9
Sales/NetFA(x) 2.9 3.0 3.0 3.0
Workingcapital/Sales(x) 0.1 0.2 0.2 0.2
Receivabledays 61.8 65.0 65.0 65.0
Inventorydays 49.8 48.2 47.1 47.2
Payabledays 46.6 50.0 50.0 50.0
Currentratio(x) 1.6 2.1 2.1 2.0
Quickratio(x) 1.1 1.4 1.4 1.3
Interestcover(x) 3.9 2.3 2.9 3.6
Dividendcover(x) 3.3 3.4 3.2 3.1
PER(x)
10.8
11.5 10.1 9.1
Price/Book(x) 1.3 1.2 1.1 1.0
EV/EBIT(x) 6.4 8.2 6.7 6.2
EV/NOPLAT(x) 7.6 10.1 7.9 7.5
EV/CE 0.9 1.0 0.9 0.9
-
7/29/2019 PC_Tata_Chem_202890446
7/9
7of9
11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE
RecommendationHistory
Recommendation Target,Rs CMP,Rs Date
Neutral 385 355 11/02/13
Buy 400 307 01/06/12
Buy 428 363 14/02/12
Neutral 400 351 28/01/11
Buy
450
390
01/11/10
Neutral 375 349 5/8/2010
Neutral 340 305 2/2/2010
Neutral 287 258 14/09/09
-
7/29/2019 PC_Tata_Chem_202890446
8/9
8of9
11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE
ManagementVineetBhatnagar(ManagingDirector) (9122)23002999
SajidKhalid(HeadInstitutionalEquities) (9122)66679972
JigneshShah(HeadEquityDerivatives) (9122)66679735
ResearchAutomobiles,ITServices
DeepakJain (9122)66679758
NehaGarg (9122)66679996
VarunVijayan (9122)66679992
Banking,NBFCs
ManishAgarwalla (9122)66679962
SachitMotwani,FRM (9122)66679953
Consumer,Media,Telecom
NaveenKulkarni,CFA,FRM (9122)66679947
EnnetteFernandes (9122)66679764
VivekanandSubbaraman (9122)66679766
Cement
VaibhavAgarwal
(9122)
6667
9967
Economics
AnjaliVerma (9122)66679969
Engineering,CapitalGoods
AnkurSharma (9122)66679759
JisharThoombath (9122)66679986
Metals
DhawalDoshi (9122)66679769
DharmeshShah (9122)66679974
Infrastructure
VibhorSinghal (9122)66679949
RaheelArathodi (9122)66679768
Oil&Gas,
FertiliserGauriAnand (9122)66679943
SaurabhRathi (9122)66679951
Retail,RealEstate
AbhishekRanganathan, CFA (9122)66679952
NehaGarg (9122)66679996
Midcaps
KapilBagaria (9122)66679965
RaheelArathodi (9122)66679768
Technicals&Quant
NeppolianPillai (9122)66679989
ShikhaKhurana (9122)66679948
Sr.ManagerEquitiesSupport
RosieFerns (9122)66679971
Sales&DistributionKinshukTiwari (9122)66679946
PawanKakumanu (9122)66679934
ShubhangiAgrawal (9122)66679964
DipeshSohani (9122)66679756
SunilKamath(SalesTrader) (9122)66679747
ChetanSavla(SalesTrader) (9122)66679745
RajeshAshar(SalesTrader) (9122)66679746
MayurShah(Execution) (9122)66679945
GurudattUchil(Execution) (9122)66679750
ContactInformation(RegionalMemberCompanies)
SINGAPORE
PhillipSecuritiesPteLtd
250NorthBridgeRoad,#0600RafflesCityTower,
Singapore179101
Tel:(65)
6533
6001
Fax:
(65)
6535
3834
www.phillip.com.sg
MALAYSIA
PhillipCapitalManagementSdnBhd
B36BlockBLevel3,MeganAvenueII,
No.12,JalanYapKwanSeng,50450KualaLumpur
Tel(60)
32162
8841
Fax
(60)
32166
5099
www.poems.com.my
HONGKONG
PhillipSecurities(HK)Ltd
11/FUnitedCentre95QueenswayHongKong
Tel(852)22776600Fax:(852)28685307
www.phillip.com.hk
JAPAN
PhillipSecuritiesJapan,Ltd
42NihonbashiKabutocho,Chuoku
Tokyo1030026
Tel:(81)336662101Fax:(81)336640141
www.phillip.co.jp
INDONESIA
PTPhillipSecuritiesIndonesia
ANZTowerLevel23B,JlJendSudirmanKav33A,
Jakarta10220,Indonesia
Tel(62)2157900800Fax:(62)2157900809
www.phillip.co.id
CHINA
PhillipFinancialAdvisory(Shanghai)Co.Ltd.
No550YanAnEastRoad,OceanTowerUnit2318
Shanghai200001
Tel(86)2151699200Fax:(86)2163512940
www.phillip.com.cn
THAILAND
PhillipSecurities(Thailand)PublicCo.Ltd.
15thFloor,VorawatBuilding, 849SilomRoad,
Silom,Bangrak,Bangkok10500Thailand
Tel(66)222680999 Fax:(66)222680921
www.phillip.co.th
FRANCE
King&ShaxsonCapitalLtd.
3rdFloor,35RuedelaBienfaisance
75008ParisFrance
Tel(33)145633100Fax:(33)145636017
www.kingandshaxson.com
UNITEDKINGDOM
King&ShaxsonLtd.
6thFloor,CandlewickHouse,120CannonStreet
London,EC4N6AS
Tel(44)2079295300Fax:(44)2072836835
www.kingandshaxson.com
UNITEDSTATES
PhillipFuturesInc.
141W
Jackson
Blvd
Ste
3050
TheChicagoBoardofTradeBuilding
Chicago,IL60604USA
Tel(1)3123569000Fax:(1)3123569005
AUSTRALIA
PhillipCapitalAustralia
Level37,
530
Collins
Street
Melbourne,Victoria3000,Australia
Tel:(61)396298380 Fax:(61)396148309
www.phillipcapital.com.au
SRILANKA
AshaPhillipSecuritiesLimited
Level4,
Millennium
House,
46/58
Navam
Mawatha,
Colombo2,SriLanka
Tel:(94)11 2429100Fax:(94)112429199
www.ashaphillip.net/home.htm
INDIA
PhillipCapital(India)PrivateLimited
No.1,CBlock,2nd
Floor,ModernCenter,JacobCircle,K.K.Marg,MahalaxmiMumbai400011
Tel:(9122)23002999Fax:(9122)66679955www.phillipcapital.in
-
7/29/2019 PC_Tata_Chem_202890446
9/9
9of9
11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE
DisclosuresandDisclaimers
PhillipCapital (India) Pvt. Ltd. has three independent equity research groups: Institutional Equities, Institutional Equity Derivatives and Private Client Group. This
reporthasbeenpreparedby Institutional EquitiesGroup.Theviewsandopinionsexpressed inthisdocumentmayormaynotmatchormaybecontraryattimes
withtheviews,estimates,rating,targetpriceoftheotherequityresearchgroupsofPhillipCapital(India)Pvt.Ltd.
ThisreportisissuedbyPhillipCapital (India)Pvt.Ltd.whichisregulatedbySEBI.PhillipCapital (India)Pvt.Ltd.isasubsidiaryofPhillip(Mauritius)Pvt.Ltd.References
to"PCIPL"inthisreportshallmeanPhillipCapital(India)Pvt.Ltdunlessotherwisestated.ThisreportispreparedanddistributedbyPCIPLforinformationpurposes
onlyandneithertheinformation containedhereinnoranyopinionexpressedshouldbeconstruedordeemedtobeconstruedassolicitationorasofferingadvicefor
thepurposesofthepurchaseorsaleofanysecurity,investment orderivatives.Theinformation andopinionscontainedintheReportwereconsideredbyPCIPLtobe
validwhenpublished.Thereportalsocontainsinformation providedtoPCIPLbythirdparties.Thesourceofsuchinformationwillusuallybedisclosedinthereport.
WhilstPCIPLhastakenallreasonablestepstoensurethatthisinformationiscorrect,PCIPLdoesnotofferanywarrantyastotheaccuracyorcompleteness ofsuch
information. AnypersonplacingrelianceonthereporttoundertaketradingdoessoentirelyathisorherownriskandPCIPLdoesnotacceptanyliabilityasaresult.
Securities and Derivatives markets may be subject to rapid and unexpected price movements and past performance is not necessarily an indication to future
performance.
Thisreportdoesnothaveregardtothespecificinvestmentobjectives,financialsituationandtheparticular needsofanyspecificpersonwhomayreceivethisreport.
Investorsmustundertakeindependentanalysiswiththeirownlegal,taxandfinancialadvisorsandreachtheirownregardingtheappropriateness ofinvestinginany
securitiesorinvestment strategiesdiscussedorrecommendedinthisreportandshouldunderstandthatstatementsregardingfutureprospectsmaynotberealized.
Innocircumstances itbeusedorconsideredasanoffertosellorasolicitationofanyoffertobuyorselltheSecuritiesmentionedinit.Theinformationcontainedin
theresearchreportsmayhavebeentakenfromtradeandstatisticalservicesandothersources,whichwebelievearereliable.PhillipCapital (India)Pvt.Ltd.oranyof
its group/associate/affiliate companies do not guarantee that such information is accurate or complete and it should not be relied upon as such. Any opinions
expressedreflectjudgmentsatthisdateandaresubjecttochangewithoutnotice
Important:These
disclosures
and
disclaimers
must
be
read
in
conjunction
with
the
research
report
of
which
it
forms
part.
Receipt
and
use
of
the
research
report
is
subjecttoallaspectsofthesedisclosures anddisclaimers.Additional informationaboutthe issuersandsecuritiesdiscussed inthisresearchreport isavailableon
request.
Certifications: The research analyst(s) who prepared this research report hereby certifies that the views expressed in this research report accurately reflect the
researchanalystspersonalviewsaboutallofthesubject issuersand/orsecurities,thattheanalysthavenoknownconflictofinterestandnopartoftheresearch
analystscompensation was, isorwillbe,directlyor indirectly,relatedtothespecificviewsorrecommendations contained inthis researchreport.TheResearch
Analystcertifiesthathe/sheorhis/herfamilymembersdoesnotownthestock(s)coveredinthisresearchreport.
Independence: PhillipCapital(India)Pvt.Ltd.hasnothadan investment bankingrelationshipwith,andhasnotreceivedanycompensationforinvestmentbanking
servicesfrom,thesubjectissuersinthepasttwelve(12)months,andPhillipCapital(India)Pvt.Ltddoesnotanticipatereceivingorintendtoseekcompensationfor
investment bankingservicesfromthesubjectissuersinthenextthree(3)months.PhillipCapital(India)Pvt.Ltdisnotamarketmakerinthesecurities mentionedin
thisresearchreport,althoughitoritsaffiliatesmayholdeitherlongorshortpositionsinsuchsecurities.PhillipCapital(India)Pvt.Ltddoesnotholdmorethan1%of
thesharesofthecompany(ies)coveredinthisreport.
SuitabilityandRisks:Thisresearchreportisforinformationalpurposesonlyandisnottailoredtothespecificinvestmentobjectives,financialsituationorparticular
requirements ofanyindividualrecipienthereof.Certainsecuritiesmaygiverisetosubstantialrisksandmaynotbesuitableforcertaininvestors.Eachinvestormust
makeits
own
determination
as
to
the
appropriateness
of
any
securities
referred
to
in
this
research
report
based
upon
the
legal,
tax
and
accounting
considerations
applicable to such investor and its own investment objectives or strategy, its financial situation and its investing experience. The value of any security may be
positivelyoradverselyaffectedbychangesinforeignexchangeorinterestrates,aswellasbyotherfinancial,economicorpoliticalfactors.Pastperformanceisnot
necessarilyindicativeoffutureperformance orresults.
Sources, Completeness and Accuracy: The material herein is based upon information obtained from sources that PCIPL and the research analyst believe to be
reliable,butneitherPCIPL northe researchanalystrepresents orguaranteesthatthe information contained herein isaccurateorcompleteand it should not be
relieduponassuch.Opinionsexpressedhereinarecurrentopinionsasofthedateappearingonthismaterialandaresubjecttochangewithoutnotice.Furthermore,
PCIPLisundernoobligation toupdateorkeeptheinformationcurrent.
Copyright:ThecopyrightinthisresearchreportbelongsexclusivelytoPCIPL.Allrightsarereserved.Anyunauthorized useordisclosure isprohibited.Noreprintingor
reproduction, inwholeor inpart, ispermittedwithoutthePCIPLspriorconsent,exceptthatarecipientmayreprintitforinternalcirculationonlyandonlyif it is
reprintedinitsentirety.
Caution: Riskof loss intrading incanbesubstantial. Youshouldcarefullyconsiderwhethertrading isappropriate foryou in lightofyourexperience,objectives,
financialresources andotherrelevantcircumstances.
PhillipCapital(India)Pvt.Ltd.
2ndFloor,CBlock,ModernCentre,Mahalaxmi,Mumbai 400011